<DOC>
	<DOCNO>NCT02487316</DOCNO>
	<brief_summary>The purpose study determine efficacy safety crizotinib combine CHOP chemotherapy patient ALK ( + ) Systemic Anaplastic Large Cell Lymphoma .</brief_summary>
	<brief_title>A Study Treatment ALK ( + ) Systemic Anaplastic Large Cell Lymphoma With Crizotinib</brief_title>
	<detailed_description>ALK ( + ) Systemic Anaplastic Large Cell Lymphoma patient treat crizotinib receive CHOP chemotherapy . crizotinib 250mg twice day administrate day 1 chemotherapy 18 week . standard CHOP chemotherapy ( cyclophosphamide , 750mg per square meter body-surface area , d1 , vincristine , 1.4mg per square meter body-surface area , maximal dose 2mg d1 , doxorubicin , 50mg per square meter body-surface area d1 , plus prednison , 100 mg d1-5 ) every 3 week six cycle .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma , Large-Cell , Anaplastic</mesh_term>
	<mesh_term>Crizotinib</mesh_term>
	<criteria>primary ALK ( + ) systemic anaplastic large cell lymphoma histologically confirm biopsy without therapy ECOG 02 1 measurable lesion major axis &gt; 1.5cm minor axis &gt; 1.0cm estimate survival &gt; /3months Age 1865 year Women childbearing age negative pregnancy test ; men woman need agree use effective contraception period treatment follow 1 year Signature inform consent Age &lt; \ 18years without ALK ( + ) systemic anaplastic large cell lymphoma histologically confirm biopsy without measurable lesion treat drug clinical trial Pregnant lactate woman , willing take contraceptive measure study period , willing use effective contraceptive measure period treatment follow 1 year Hepatic insufficiency : serum total bilirubin , ALT 2 time higher normal Renal insufficiency : 2 time higher normal serum creatinine Blood screening period : WBC &lt; 1 * 109/L * 109/L ; platelet &lt; 25 ; Hb &lt; 60g/L HIV test positive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Anaplastic Large Cell Lymphoma</keyword>
	<keyword>anaplastic lymphoma kinase rearrangement</keyword>
	<keyword>crizotinib</keyword>
	<keyword>CHOP chemotherapy</keyword>
</DOC>